Your browser doesn't support javascript.
loading
Light exacerbates local and global effects induced by pH unfolding of Ipilimumab.
Rizzotto, Elena; Inciardi, Ilenia; Fongaro, Benedetta; Trolese, Philipp; Miolo, Giorgia; Polverino de Laureto, Patrizia.
Affiliation
  • Rizzotto E; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 30131 Padova, Italy.
  • Inciardi I; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 30131 Padova, Italy.
  • Fongaro B; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 30131 Padova, Italy.
  • Trolese P; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 30131 Padova, Italy.
  • Miolo G; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 30131 Padova, Italy.
  • Polverino de Laureto P; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 30131 Padova, Italy. Electronic address: patrizia.polverinodelaureto@unipd.it.
Eur J Pharm Biopharm ; 201: 114387, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38944210
ABSTRACT
Monoclonal antibodies (mAbs) are an essential class of therapeutic proteins for the treatment of cancer, autoimmune and rare diseases. During their production, storage, and administration processes, these proteins encounter various stressors such as temperature fluctuations, vibrations, and light exposure, able to induce chemico-physical modifications to their structure. Viral inactivation is a key step in downstream processes, and it is achieved by titration of the mAb at low pH, followed by neutralization. The changes of the pH pose a significant risk of unfolding and subsequent aggregation to proteins, thereby affecting their manufacturing. This study aims to investigate whether a combined exposure to light during the viral inactivation process can further affect the structural integrity of Ipilimumab, a mAb primarily used in the treatment of metastatic melanoma. The biophysical and biochemical characterization of Ipilimumab revealed that pH variation is a considerable risk for its stability with irreversible unfolding at pH 2. The threshold for Ipilimumab denaturation lies between pH 2 and 3 and is correlated with the loss of the protein structural cooperativity, which is the most critical factor determining the protein refolding. Light has demonstrated to exacerbate some local and global effects making pH-induced exposed regions more vulnerable to structural and chemical changes. Therefore, specific precautions to real-life exposure to ambient light during the sterilization process of mAbs should be considered to avoid loss of the therapeutic activity and to increase the yield of production. Our findings underscore the critical role of pH optimization in preserving the structural integrity and therapeutic efficacy of mAbs. Moreover, a detailed conformational study on the structural modifications of Ipilimumab may improve the chemico-physical knowledge of this effective drug and suggest new production strategies for more stable products under some kind of stress conditions.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ipilimumab / Light Limits: Humans Language: En Journal: Eur J Pharm Biopharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ipilimumab / Light Limits: Humans Language: En Journal: Eur J Pharm Biopharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: Italy